| |
| |
|
| Insider
Information: |
Mckearn Thomas J |
| Relationship: |
President, R&D |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
73,137 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,761 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
73,137 |
|
|
| Total
Value |
$6,761 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Advaxis Inc |
ADXS |
Director |
2016-12-20 |
69,804 |
|
0 |
Premium* |
|
|
Onconova Therapeutics, Inc. |
ONTX |
President, R&D |
2013-07-30 |
3,333 |
2013-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADXS |
Advaxis Inc |
Director |
– • – |
2016-12-20 |
4 |
S |
$8.08 |
$99,513 |
D/D |
(12,316) |
69,804 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2016-05-13 |
4 |
S |
$7.45 |
$30,545 |
D/D |
(4,100) |
82,120 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2016-03-16 |
4 |
S |
$8.25 |
$115,500 |
D/D |
(14,000) |
86,220 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2015-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
100,220 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2014-11-03 |
4 |
D |
$3.04 |
$40,809 |
D/D |
(13,424) |
85,220 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2014-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,115 |
98,644 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2014-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
73,529 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2013-11-18 |
4 |
A |
$4.85 |
$49,999 |
D/D |
10,309 |
23,529 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
President, R&D |
• – – |
2013-07-30 |
4 |
B |
$15.00 |
$49,995 |
D/D |
3,333 |
3,333 |
2.74 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2013-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,353,333 |
1,652,623 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
299,290 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2004-11-12 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
179,290 |
|
- |
|
| ADXS |
Advaxis Inc |
Director |
– • – |
2004-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
111,015 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
